Ascent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ASCENT PHARMS INC, and what generic and branded alternatives to ASCENT PHARMS INC drugs are available?
ASCENT PHARMS INC has thirty-two approved drugs.
Drugs and US Patents for Ascent Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ascent Pharms Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 207416-003 | Sep 22, 2015 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Ascent Pharms Inc | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 215523-006 | Dec 8, 2021 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Ascent Pharms Inc | BENZONATATE | benzonatate | CAPSULE;ORAL | 211518-002 | Feb 22, 2019 | AA | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.